noon trading 4 noon trading cigna ci 102 11 8903 light volume thus far 427243 shares cigna exchanged hands compared average daily volume 15 million shares stock ranged price 88789063 opened day 9024 compared previous trading days close 9005 cigna corporation health services organization provides insurance related products services united states internationally cigna market cap 243 billion part health services industry company pe ratio 134 sp 500 pe ratio 177 shares 29 yeartodate close trading thursday currently 8 analysts rate cigna buy analysts rate sell 6 rate hold cigna corporation health services organization provides insurance related products services united states internationally cigna market cap 243 billion part health services industry company pe ratio 134 sp 500 pe ratio 177 shares 29 yeartodate close trading thursday currently 8 analysts rate cigna buy analysts rate sell 6 rate hold thestreet ratings rates cigna thestreet ratings ratesas buy companys strengths seen multiple areas revenue growth largely solid financial position reasonable debt levels measures solid stock price performance growth earnings per share good cash flow operations feel strengths outweigh fact company shows low profit margins get full cigna ratings report stocks buy thestreet quant ratings identified handful stocks potentially triple next 12 months learn
noon trading 3 noon trading valeant pharmaceuticals international vrx 075 06 13142 average volume thus far 826653 shares valeant pharmaceuticals international exchanged hands compared average daily volume 11 million shares stock ranged price 1296913208 opened day 13181 compared previous trading days close 13217 valeant pharmaceuticals international inc specialty pharmaceutical company develops manufactures markets pharmaceutical products medical devices areas neurology dermatology branded generics valeant pharmaceuticals international market cap 427 billion part drugs industry shares 126 yeartodate close trading thursday currently 9 analysts rate valeant pharmaceuticals international buy 1 analyst rates sell none rate hold valeant pharmaceuticals international inc specialty pharmaceutical company develops manufactures markets pharmaceutical products medical devices areas neurology dermatology branded generics valeant pharmaceuticals international market cap 427 billion part drugs industry shares 126 yeartodate close trading thursday currently 9 analysts rate valeant pharmaceuticals international buy 1 analyst rates sell none rate hold thestreet ratings rates valeant pharmaceuticals international thestreet ratings ratesas hold companys strengths seen multiple areas robust revenue growth solid stock price performance good cash flow operations however counter strengths also find weaknesses including feeble growth companys earnings per share deteriorating net income generally higher debt management risk get full valeant pharmaceuticals international ratings report stocks buy thestreet quant ratings identified handful stocks potentially triple next 12 months learn
noon trading 2 noon trading wellpoint wlp 101 11 9199 light volume thus far 675245 shares wellpoint exchanged hands compared average daily volume 21 million shares stock ranged price 90869295 opened day 9274 compared previous trading days close 9300 wellpoint inc health benefits company subsidiaries offers networkbased managed care plans large small employer individual medicaid senior markets united states company operates three segments commercial consumer wellpoint market cap 272 billion part health services industry company pe ratio 100 sp 500 pe ratio 177 shares 07 yeartodate close trading thursday currently 5 analysts rate wellpoint buy analysts rate sell 11 rate hold wellpoint inc health benefits company subsidiaries offers networkbased managed care plans large small employer individual medicaid senior markets united states company operates three segments commercial consumer wellpoint market cap 272 billion part health services industry company pe ratio 100 sp 500 pe ratio 177 shares 07 yeartodate close trading thursday currently 5 analysts rate wellpoint buy analysts rate sell 11 rate hold thestreet ratings rates wellpoint thestreet ratings ratesas buy companys strengths seen multiple areas revenue growth largely solid financial position reasonable debt levels measures solid stock price performance attractive valuation levels good cash flow operations feel strengths outweigh fact company sub par growth net income get full wellpoint ratings report stocks buy thestreet quant ratings identified handful stocks potentially triple next 12 months learn
